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DCONCLUSIONS
Patients undergoing IAA repair are at persistent risk of
subsequent procedures and mortality. Complex inter-
relationships exist among these subsequent procedures.
IAA is a chronic disorder and not a structural anomaly de-
finitively treated in the newborn period, a message that
should be made clear to practitioners, patients, and their
families alike.
We thank all the participating member institutions listed in
Appendix 1, because, without their data, the present study would
not have been possible.We also acknowledge the assistance of per-
sonnel from the CHSS Data Center, in particular, Olga Levesque
and Maulik Baxi, for coordinating the collection and management
of these data.
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Dr Charles D. Fraser (Houston, Tex). Dr Jegatheeswaran and
colleagues have really conducted another elegant study from the
Congenital Heart Surgeons’ Society. I also think it is important
to acknowledge that Anusha Jegatheeswaran is the John Kirklin/
David Ashburn Fellow at the Congenital Heart Surgeons’ Society
Data Center and is due to complete her PhD in a year and did
a wonderful job. I also appreciate her spending a lot of time with
me reviewing these very complicated statistics in advance of this
presentation.
This study builds on previous work that examined the outcomes
in patients with an interrupted aortic arch. The novel aspects of the
present study include the evaluation of factors leading to, and the
effect of, recurrent arch and left ventricular outflow tract (LVOT)
obstruction. Specifically, the study examines time-related rates of,
and associated factors for, subsequent arch and LVOT procedures
after the initial interrupted aortic arch repair, in addition to exam-
ining mortality.
The results are somewhat disappointing, yet likely confirma-
tory, of what I expect most surgeons believe, and that is, that sur-
gically repaired interrupted aortic arch is a chronic diseasewith the
need for long-term follow-up.
Without further recapitulating the data, I will again summarize,
as I understand it, the paper’s principal findings. One, multiple pro-
cedures after the index operation are common. Second, the risk of
subsequent arch procedures decreased after each subsequent arch
procedure and the chronic risk of LVOT procedures increased after
each subsequent procedure. Third, the factors associated with sub-
sequent arch procedures were related to previous procedures, as
well as the characteristics of the anatomy and of the index repair.
Of interest, the acute risk of subsequent arch procedure was great-
est if the most proximate arch procedure was a catheter interven-
tion. Finally, the need for subsequent procedures after the index
operations adversely affects survival.
I would again like to congratulate you on this presentation, and I
am left with several questions of practical significance.
What have we learned from this study that will be of value to
current practice, specifically what implications did this study bring
in terms of the conduct of the primary operation, a better way to
repair the arch, a more aggressive stance to deal with the left ven-
tricular outflow tract, or others?gery c November 2010
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DDr Jegatheeswaran. Thank you very much for your comments
and your question, Dr Fraser.
With respect to the aortic arch, we really have not definitively
determined the best procedure, because it depends on the patient’s
individual characteristics and circumstances, some of which were
measured and some of which remain unknown. To definitively ad-
dress issues of therapy, a randomized, controlled trial, is required,
which is particularly difficult in a pediatric population with a rare
disease, and can only address one issue at a time. However, from
the literature, we know that single centers such as the Texas Chil-
dren’s Hospital in Houston and the Riley Hospital for Children in
Indianapolis, have demonstrated excellent results with a dedicated
team using only one type of approach, whether that be a direct or
staged repair. These observational studies do not, however, tell us
which technique is better, they only tell us that either can achieve
good results.
With regard to the LVOT, the nature of the lesion is multifac-
eted. A reluctance to address lesions or an inability to predict
the progression of lesions at the index procedure might explain
the increasing risk of additional subsequent procedures. It is pos-
sible that a more definitive procedure performed early might re-
duce the risk subsequent procedures for the LVOT.
Regarding catheter-based procedures, those directed at the arch
were shown to be less durable than those performed surgically. For
the LVOT, catheter-based procedures were directed primarily at
the aortic valve, which does not usually provide definitive treat-
ment. Catheter-based procedures directed at subaortic obstruction
have not been shown to be of long-term benefit. Nonetheless, how-
ever, we still might be tempted, as surgeons, to offer patients cath-
eter-based procedures in the hope of avoiding or delaying more
invasive procedures.
Dr Fraser. I think you have answered this in part already, but
how should we use these data to counsel parents and patients?
Dr Jegatheeswaran. The most important thing that parents and
patients should be counseled about is that the interrupted aortic
arch could be a chronic disease. Patients will need long-term fol-
low-up and might require multiple subsequent procedures. In addi-
tion, that with each successive procedure, overall mortality is
increased. In discussions with patients during follow-up encoun-
ters, counseling should emphasize the need for ongoing cardiology
follow-up and arrangements for appropriate transition to adult care.
Genetic counseling should be included for those diagnosed with
DiGeorge syndrome or chromosome 22q11 deletion syndrome.
Finally, based on the results of our study, parents and patients
should be encouraged by our contemporary abilities to perform
both the primary repair, as well as the subsequent procedures, in
addition to the evolution of catheter-based techniques, which are
constantly improving.
Dr Fraser. Then, finally, I realize that you were limited in time
in the presentation and that prohibited complete elucidation of the
demographic, morphologic, and procedural predictors of arch and
LVOT reintervention and mortality, but could you share some of
those data with us.
Dr Jegatheeswaran. The factors that were not directly reported
were those that were thought to be congruent with previous
studies.
For subsequent arch procedures, these included a younger age
at the index repair; whether a patient was born earlier in the studyThe Journal of Thoracic and Carperiod; the presence of associated cardiac anomalies; whether the
index repair included LVOT repair; whether the left subclavian or
a Gore-Tex interposition graft was used to repair the arch at the in-
dex procedure; and whether the ventricular septal defect was left
open at the index repair, possibly indicating a staged procedure.
Regarding the LVOT, the presence of a small- or medium-size
ventricular septal defect; the presence of an anomalous right sub-
clavian artery; and the use of a polytetrafluroethylene graft or a pul-
monary homograft for index arch repair increased the risk of
a subsequent LVOT procedure.
Regarding mortality, the risk factors included being born earlier
in the study period, male gender, and the presence of a small- or
medium-size ventricular septal defect, associated cardiac anoma-
lies, or left-sided hypoplasia. Additional factors increasing the
risk of mortality that were present at the index arch repair included
lower weight, an approach by way of a median sternotomy, and
placement of a pulmonary artery band or a systemic-to-pulmonary
arterial shunt.
Dr Osman O. Al-Radi (Toronto, Ontario, Canada). I would
like to thank you again for the long hours you spent on this study
and for the excellent presentation.
The question is: Did you study whether the risk of the LVOT
procedure changed depending on the nature of that procedure,
whether it was fibromuscular resection versus a more aggressive
procedure such as a Konno? In other words, did the type of the first
LVOT procedure affect the risk of subsequent LVOT procedures?
Dr Jegatheeswaran. Thank you, Dr Al-Radi.
For subsequent LVOT procedures, it was noted that the type and
timing of the subsequent procedures were not significantly associ-
ated with an increased risk, although the numbers and statistical
power were likely not adequate to be definitive.
Dr Francois Lacour-Gayet (New York, NY). I really enjoyed
your paper.
From a practical surgical standpoint, it is important to under-
stand what is, as you said, the optimal first operation to perform.
Also, there are clearly different types of patients, those with
a very small aortic annulus and the risk of important LVOT ob-
struction in the future, another where the aortic annulus is accept-
able. We were talking about a type A compared with a type B
obviously.
You are showing kind of alarming but classic information
about the risk of a secondary LVOT obstruction. Actually, in a se-
ries in Paris 12 years ago, we found that 30% of the patients
with an interrupted aortic arch required a secondary LVOT
procedure.
I have 2 questions. Can you try to be more specific to tell us
what was the first procedure that was most frequently performed
in your series, namely, was it a subaortic membrane resection?
For the second procedure, what was the procedure, was it a second
resection, or was it a Ross-Konno operation?
Dr Jegatheeswaran. For LVOT procedures performed con-
comitantly with index arch repair, fibromuscular resection was
the most common procedure type. For LVOT procedures
performed after the index arch repair, catheter-based aortic valve
dilations were the most common, in addition to fibromuscular re-
section.
Dr Lacour-Gayet. My final question is that knowing this and
knowing that there is a risk of nearly 35%, or even more, of latediovascular Surgery c Volume 140, Number 5 1067
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Dsubaortic obstruction, why not start by doing first an operation that
is going to fix it, namely, a neonatal Ross-Konno? Also, I under-
stand this is not exactly a question for you, but this is an idea I
just want to send out.
My personal practice has been when the aortic annulus is real
small and a type 2B, to go on and do a neonatal Ross. We do no-
t have a long series, but the results seem to be satisfactory; of
course, with the problem, I think in a Ross-Konno, the problem
that we have with the LVOT reconstruction that will require also
reoperation.
Dr Jegatheeswaran. Thank you for your comment. The current
study lacked sufficient quantitative anatomic detail to allow the1068 The Journal of Thoracic and Cardiovascular Surprediction of which patients might be expected to develop or man-
ifest important LVOTobstruction after index repair, for whom pro-
cedures to address this at the index repair might prevent the need
for subsequent procedures. This is a question that remains subop-
timally answered.
Dr Giovanni Stellin (Padova, Italy). I wonder whether you
found any difference of incidence of LVOT obstruction among
the 3 different anatomic types (A, B, C).
Dr Jegatheeswaran. For all risk analyses, an association with
anatomical type of IAAwas explored, but was not statistically sig-
nificant for either subsequent arch or subsequent left ventricular
outflow tract procedures.gery c November 2010
